Genomic damage in patients with type-2 diabetes mellitus

Genetic Counseling

Volumn 24, Issue 2, 2013, Pages 149-156

  Binici, D N ^a   Karaman, Ali ^b   Coskun M ^a   Uyanik Oglu A ^a   Ucar F ^c  

^a Erzurum Training and Research Hospital ^*  (Turkey)

^b Erzurum Nenehatun Obstetrics and Gynecology Hospital   (Turkey)

^c MUSTAFA KEMAL UNIVERSITY   (Turkey)

Author keywords

Diabetes mellitus; Micronucleus; Pathogenesis; Sister chromatid exchange

Indexed keywords

HEMOGLOBIN A1C; METFORMIN; SULFONYLUREA;

ADULT; AGED; ARTICLE; BLOOD CELL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC PATIENT; DISEASE DURATION; DNA DAMAGE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LYMPHOCYTE CULTURE; MALE; MICRONUCLEUS TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; SISTER CHROMATID EXCHANGE;

AGED; DIABETES MELLITUS, TYPE 2; DNA DAMAGE; FEMALE; HUMANS; MALE; MICRONUCLEUS TESTS; MIDDLE AGED; SISTER CHROMATID EXCHANGE;

EID: 84884321331     PISSN: 10158146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. AKKUŞ I., KALAK S., VURAL H., CAGLAYAN O., MENEKŞE E., CAN G., DURMUŞ B.: Leukocyte lipid peroxidation, superoxide dismutase, glutathione peroxidase and serum and leukocyte vitamin C levels of patients with type II diabetes mellitus. Clin. Chim. Acta, 1996, 244, 221-227.
2. AMOS A.F., MCCARTY D.J., ZIMMET P.: The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med., 1997, 14, S1-85.
3. CAKATAY U.: Protein oxidation parameters in type 2 diabetic patients with good and poor glycaemic control. Diabetes Metab., 2005, 31, 551-557.
4. CAIMI G., CAROLLO C., LO PRESTI R.: Diabetes mellitus: oxidative stress and wine. Curr. Med. Res. Opin., 2003, 19, 581-586.
5. CERIELLO A.: Oxidative stress and glycemic regulation. Metabolism, 2000, 49, 27-29.
6. CHOI S.W., BENZIE I.F., LAM C.S., CHAT S.W., LAM, J., YIU C.H., KWAN J.J., TANG Y.H., YEUNG G.S., YEUNG V.T., WOO G.C., HANNIGAN B.M., STRAIN J.J.: Inter-relationships between DNA damage, ascorbic acid and glycaemic control in Type 2 diabetes mellitus. Diabet Med., 2005, 22, 1347-1353
7. DANDONA P., THUSU K., COOK S., SNYDER B., MAKOWSKI J., ARMSTRONG D., NICOTERA T.: Oxidative damage to DNA in diabetes mellitus. Lancet, 1996, 347, 444-445.
8. FENECH M.: The in vitro micronucleus technique. Mutat. Res., 2000, 455, 81.
9. FENECH M., HOLLAND N., CHANG W.P., ZEIGER E., BONASSI S.: The Human MicroNucleus Project: an international collaborative study on the use of micronucleus technique for measuring DNA damage in humans. Mutat. Res., 1999, 428, 29.
10. FENECH M., MORLEY A.A.: Measurement of micronuclei in lymphocytes. Mutat. Res., 1985, 147, 29.
11. HALLIWELL B.: Effect of diet on cancer development: is oxidative DNA damage a biomarker? Free Radic. Bio. Med., 2002, 32, 968-974.
12. JENNINGS P.E., SCOTT N.A., SANIABADI A.R., BELCH J.J.: Effects of gliclazide on platelet reactivity and free radicals in type II diabetic patients: clinical assessment. Metabolism, 1992, 41, 36-39.
13. KANG D., HAMASAKI N.: Mitochondrial oxidative stress and mitochondrial DNA. Clin. Chem. Lab. Med, 2003, 41, 1281-1288.
14. KESAVULU M.M., RAO B.K., GIRI R., VIJAYA J., SUBRAMANYAM G., APPARAO C.: Lipid peroxidation and antioxidant enzyme status in Type 2 diabetics with coronary heart disease. Diabetes Res. Clin. Pract., 2001, 53, 33-39.
15. KIRSCH-VOLDERS M., SOFUNI T., AARDEMA M., ALBERTINI S., EASTMOND D., FENECH M., ISHIDATE M. JR., KIRCHNER S., LORGE E., MORITA T., NORPPA H., SURRALLÉS J., VANHAUWAERT A., WAKATA A.: Report from the in vitro micronucleus assay working group. Mutat. Res., 2003, 540, 153.
16. KOMOSIŃSKA-VASSEV K., OLCZYK K., OLCZYK P., WINSZ-SZCZOTKA K.: Effects of metabolic control and vascular complications on indices of oxidative stress in type 2 diabetic patients. Diabetes Res. Clin. Pract., 2005, 68, 207-216.
17. LATT S.A.: Sister chromatid exchange formation. Annu. Rev. Genet., 1981, 15, 11.
18. LATT S.A., SCHRECK R.R.: Sister chromatid exchange analysis. Am. J. Hum. Genet., 1980, 32, 297.
19. LODOVICI M., GIOVANNELLI L., PITOZZI V., BIGAGLI E., BARDINI G., ROTELLA C.M.: Oxidative DNA damage and plasma antioxidant capacity in type 2 diabetic patients with good and poor glycaemic control. Mutat. Res., 2008, 638, 98-102.
20. MARITIM A.C., SANDERS R.A., WATKINS 3RD J.B.: Diabetes, oxidative stress, and antioxidants: a review. J. Biochem. Mol. Toxicol., 2003, 17, 24-38.
21. NORPPA H.: Cytogenetic biomarkers. IARC. Sci. Publ., 2004, 157, 179.
22. NORPPA H., BONASSI S., HANSTEEN I.L., HAGMAR L., STRÖMBERG U., RÖSSNER P., BOFFETTA P., LINDHOLM C., GUNDY S., LAZUTKA J., CEBULSKA-WASILEWSKA A., FABIÁNOVÁ E., SRÁM R.J., KNUDSEN L.E., BARALE R., FUCIC A.: Chromosomal aberrations and SCEs as biomarkers of cancer risk. Mutat. Res., 2006, 600, 37.
23. OBROSOVA I.G., VAN HUYSEN C., FATHALLAH L., CAO X.C., GREENE D.A., STEVENS M.J.: An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense. FASEB J., 2002, 16, 123-125.
24. ORANJE W.A., RONDAS-COLBERS G.J., SWENNEN G.N., JANSEN H., WOLFFENBUTTEL B.H.: Lack of effect on LDL oxidation and antioxidant status after improvement of metabolic control in type 2 diabetes. Diabetes Care, 1999, 22, 2083-2084.
25. PAN H.Z., ZHANG H., CHANG D., LI H., SUI H.: The change of oxidative stress products in diabetes mellitus and diabetic retinopathy. Br. J. Ophthalmol., 2008, 92, 548-551.
26. SAMCOVA E., KVASNICOVA V.: Oxidative stress and 8-hydroxy- 2′deoxyguanosine as a biomarker of oxidative DNA damage. DMEV, 2000, 3, 194-198.
27. STADTMAN E.R., BERLETT B.S.: Reactive oxygen-mediated protein oxidation in aging and disease. Drug Metab. Rev., 1998, 30, 225-243.
28. VAN DAM P.S., VAN ASBECK B.S., ERKELENS D.W., MARX J.J., GISPEN W.H., BRAVENBOER B.: The role of oxidative stress in neuropathy and other diabetic complications. Diabetes Metab. Rev., 1995, 11, 181-192.
29. VAN DELFT J.H.M., BAAN R.A., ROZA L.: Biological effect markers for exposure to carcinogenic compound and their relevance for risk assessment. Crit. Rev. Toxicol., 1998, 28, 477
30. WILSON III. D.M., THOMPSON L.M.: Molecular mechanisms of sister chromatid exchange. Mutat. Res., 2007, 616, 11.